Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a
prevalence rate of 5–10% in reproductive aged women. It's characterized by (1) chronic …

Polycystic ovarian syndrome (PCOS) is a prevailing endocrine and metabolic disorder
occurring in about 6–20% of females in reproductive age. Most symptoms of PCOS arise …

Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

BACKGROUND Our prior meta-analyses demonstrated an increased prevalence of
impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) with polycystic ovary …

Background: We aimed to assess general practitioners'(GPs) knowledge, attitudes, and
practices (KAPs) toward screening recommendation guidelines of the United States …

BACKGROUND Polycystic ovary syndrome (PCOS) is a common condition in reproductive-
aged women associated with impaired glucose tolerance (IGT), type 2 diabetes mellitus …

Polycystic ovary syndrome (PCOS) is the most common, heterogeneous, and multifactorial
endocrine disorder in premenopausal women. The pathophysiology of this endocrinopathy …

Women with polycystic ovary syndrome (PCOS) have a considerable risk of metabolic
dysfunction. This review aims to present contemporary knowledge on obesity, insulin …

Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …

Polycystic ovary syndrome (PCOS), a multisystem disease, is a major reason for female
infertility around the world. It is no longer considered simply as a disease of ovary. Now …